Endometriosis and Ehlers-Danlos Syndrome (EDS)

Ehlers-Danlos Syndrome (EDS) is a group of hereditary connective tissue disorders that affect collagen, the protein responsible for maintaining the structure and elasticity of the skin, joints, and various organs. While EDS is known for its hallmark symptoms such as joint hypermobility, skin fragility, and chronic pain, it also manifests in ways that overlap with other conditions, including gynecological issues. Endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, is one such condition that shares symptoms with EDS. Understanding the relationship between these two conditions is crucial for improving diagnosis and treatment for affected individuals.

Prevalence of Endometriosis in EDS

While both EDS and endometriosis are distinct conditions, they can coexist. Studies estimate that 6-23% of individuals with EDS also have endometriosis​​. However, the prevalence of endometriosis among EDS patients is not significantly higher than in the general population, where it affects approximately 10% of reproductive-age women​​. Chronic pelvic pain, a hallmark symptom of endometriosis, is also reported by over 92% of women with EDS, complicating differential diagnosis​​.

One study found that endometriosis is often overdiagnosed in EDS patients due to overlapping symptoms such as menorrhagia (heavy menstrual bleeding), dysmenorrhea (painful periods), and dyspareunia (pain during intercourse)​​. These symptoms, while common in endometriosis, can also result directly from the connective tissue abnormalities in EDS.

Pathophysiological Mechanisms of Overlap between EDS and Endometriosis

The biological overlap between EDS and endometriosis is an area of growing interest. In EDS, abnormalities in collagen and connective tissue can lead to structural weaknesses in the uterus and surrounding organs​​. This fragility may exacerbate menstrual pain and contribute to symptoms often attributed to endometriosis.

Additionally, mast cell activation syndrome (MCAS), frequently observed in EDS, could play a role in the inflammatory processes associated with endometriosis. Dysregulated mast cells release histamine and other inflammatory mediators, potentially intensifying pain and inflammation​.

Hormonal fluctuations are another shared factor. EDS symptoms often worsen during puberty, menstruation, and pregnancy due to changes in estrogen levels​​. Similarly, estrogen plays a key role in the development and progression of endometriosis, highlighting a possible hormonal link between the two conditions.

Challenges in Diagnosis of co-occuring EDS and Endometriosis

Differentiating between EDS and endometriosis can be challenging. Both conditions share symptoms such as chronic pelvic pain, fatigue, and gastrointestinal disturbances​​. However, while endometriosis is typically diagnosed via laparoscopy or imaging, EDS is diagnosed through clinical evaluation using tools such as the Beighton score and genetic testing​.

Delayed or missed diagnoses are common in patients with coexisting EDS and endometriosis. Women with EDS are often misdiagnosed with endometriosis based solely on pelvic pain and abnormal bleeding, leading to unnecessary surgical interventions​​. A multidisciplinary approach involving gynecologists, rheumatologists, and pain specialists is critical for accurate diagnosis and effective treatment.

EDS and Endometriosis Treatment Strategies

Managing symptoms of EDS and endometriosis requires an individualized, multidisciplinary approach.

For EDS-related gynecological symptoms:

• Hormonal therapies, such as oral contraceptives or progesterone-only medications, can reduce menstrual pain and bleeding. Studies indicate that hormonal treatments may improve symptoms in some EDS patients, though others may experience worsening​​.
• Non-steroidal anti-inflammatory drugs (NSAIDs) and supplements like magnesium are recommended for managing dysmenorrhea​​.

For endometriosis:

• Hormonal treatments such as GnRH agonists and progestin therapies are effective in reducing lesion growth and pain​.
• Surgical interventions may be necessary in severe cases, though these should be approached with caution in EDS patients due to their increased risk of poor wound healing and tissue fragility​​.

Physical therapy and pain management:

• Physical therapy focusing on pelvic floor stabilization is beneficial for both conditions. For EDS patients, strengthening surrounding muscles can provide additional joint support​​.
• Pain management techniques, including acupuncture and mindfulness, can help alleviate chronic pain and improve quality of life​.

Impact on Quality of Life

Living with both EDS and endometriosis can significantly impact a person’s physical and emotional well-being. Chronic pain, fatigue, and reproductive challenges contribute to a diminished quality of life​​. Patients often report frustration with delayed diagnoses and inadequate treatment, underscoring the need for better awareness among healthcare providers​.

Psychological support, including counseling and support groups, is essential for helping patients cope with these chronic conditions. Building a comprehensive care plan that addresses both physical and emotional health can empower patients to manage their symptoms effectively.

Conclusion

The overlap between EDS and endometriosis highlights the complexity of diagnosing and treating these conditions. While research continues to explore their potential connections, it is clear that a multidisciplinary approach is crucial for managing symptoms and improving outcomes. Greater awareness among healthcare providers and patients can lead to earlier diagnoses, more targeted treatments, and ultimately, a better quality of life for those living with EDS and endometriosis.

‍

FAQ

Is there a link between EDS and endometriosis?
Yes, there appears to be a link between Ehlers-Danlos Syndrome (EDS) and endometriosis, with studies suggesting that 6-23% of people with EDS may also have endometriosis. However, shared symptoms like chronic pelvic pain can lead to misdiagnosis or overlapping conditions.

What autoimmune disease causes endometriosis?
Endometriosis itself is not classified as an autoimmune disease, but it often coexists with autoimmune conditions like lupus, rheumatoid arthritis, or Hashimoto's thyroiditis. This association may be due to shared immune system dysregulation.

Can endometriosis cause histamine-related issues?
Yes, endometriosis can cause histamine-related issues, often through inflammation and interactions with mast cells. Histamine release may exacerbate symptoms such as pain, bloating, or allergic-type reactions in some individuals.

What syndrome is associated with endometriosis?
Irritable Bowel Syndrome (IBS) is commonly associated with endometriosis, as both can cause overlapping symptoms like abdominal pain, diarrhea, and constipation. This can complicate diagnosis and management of either condition.

Is endometriosis a mitochondrial disease?
No, endometriosis is not classified as a mitochondrial disease. However, research suggests mitochondrial dysfunction may play a role in the development and progression of endometriosis, particularly in how cells manage energy and oxidative stress.

Can endometriosis cause mast cell activation?
Yes, endometriosis can contribute to mast cell activation. Mast cells, which are involved in the body’s inflammatory response, may become overactive in endometriosis, leading to heightened pain and inflammation.

What hormone aggravates endometriosis?
Estrogen aggravates endometriosis by promoting the growth of endometrial-like tissue outside the uterus. High estrogen levels can intensify symptoms and worsen lesion development.

What autoimmune diseases can endometriosis cause?
Endometriosis does not directly cause autoimmune diseases, but it is often associated with autoimmune conditions such as lupus, multiple sclerosis, and Sjögren’s syndrome. The shared immune dysfunction may explain this correlation.

‍
References

1. McIntosh, L. J., et al. "Gynecologic Disorders in Women with Ehlers-Danlos Syndrome." Journal of the Society for Gynecologic Investigation, vol. 2, no. 3, 1995, pp. 559-564. DOI:10.1016/1071-5576(94)00050-b.
2. Blagowidow, N. "OB/GYN and EDS/HDS." Ehlers-Danlos Society Annual Conference Presentation, 2018. Retrieved from https://www.ehlers-danlos.com/pdf/2018-annual-conference/N-Blagowidow-2018Baltimore-OB-GYN-and-EDS-HSD-S.pdf.
3. Hugon-Rodin, J., et al. "Gynecologic Symptoms and the Influence on Reproductive Life in 386 Women with Hypermobility Type Ehlers-Danlos Syndrome: A Cohort Study." Orphanet Journal of Rare Diseases, vol. 11, 2016, pp. 124. DOI:10.1186/s13023-016-0511-2.
4. Jesse, N., and A. Yunker. "Prevalence of Endometriosis and Pelvic Pain in Patients with Hereditary Connective Tissue Disorders." American Journal of Obstetrics & Gynecology, vol. 230, issue 4, Supplement, 2024, S1198-S1199. DOI:10.1016/j.ajog.2024.02.092.
5. Castori, M. "Ehlers-Danlos Syndrome, Hypermobility Type: An Underdiagnosed Hereditary Connective Tissue Disorder with Mucocutaneous, Articular, and Systemic Manifestations." International Scholarly Research Notices, 2012. DOI:10.5402/2012/751768.
6. Endo Belly Coach Podcast. "Endometriosis and Ehlers-Danlos Syndrome: Is There a Connection?" The Endo Belly Coach, 2024. Retrieved from https://www.theendobellycoach.com/podcast/endometriosis-and-ehlers-danlos-syndrome.
7. Hurst, B. S., et al. "Reproductive Challenges in Women with Ehlers-Danlos Syndrome: Survey Results from Over 1,350 Respondents." Obstetrics and Gynecology, Carolinas Medical Center, 2012.
8. Blagowidow, N. "Obstetrics and Gynecology in Ehlers-Danlos Syndrome: A Brief Review and Update." American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol. 187, no. 4, 2021, pp. 593-598. DOI:10.1002/ajmg.c.31945.
9. Parasar, P., et al. "Endometriosis: Epidemiology, Diagnosis, and Clinical Management." Current Obstetrics and Gynecology Reports, vol. 6, no. 1, 2017, pp. 34-41. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737931.

‍